HB 480 amends Utah's medical record laws to clarify abortion classifications. It defines "elective abortion" as one not needed for health reasons and "medically indicated abortion" as one required to save a woman's life, treat a pregnancy loss, or address serious health risks. The bill allows patients to request that their medical records reflect a prior abortion as "not elective" (i.e., medically necessary), and requires healthcare providers to update records upon such a request. These changes affect patients who have had abortions and the healthcare providers maintaining their records, with no new funding or major procedural shifts.
HB 216 amends Utah's child support law to exclude Social Security Disability Insurance (SSDI) benefits from the gross income calculation used to determine child support payments. This change directly affects parents who receive SSDI, ensuring these disability benefits are not counted as income when calculating their child support obligation. The bill modifies Utah Code Section 81-6-203 by adding SSDI to a list of excluded benefits, alongside other means-tested programs like Medicaid and SNAP. This adjustment aligns with existing exclusions for similar benefits and prevents SSDI recipients from having these funds considered as available income for support payments. The change takes effect May 6, 2026.
HB 338 requires all Utah first responder agencies to provide mental health services to current first responders, their spouses and children, surviving spouses of line-of-duty deaths, and retired or separated first responders (and their spouses) for three years after separation. It creates a Mental Health Resources Reserve Account funded by agency contributions to provide grants for mental health plans, prioritizing small agencies, and mandates the Department of Public Safety to submit annual compliance reports to specific committees and a public safety portal. The bill also updates grant application requirements to ensure providers have first responder-specific experience and outlines detailed plan criteria for agencies seeking funding. No new state funds are appropriated; existing resources will support these expanded services.
HB 156 allows patients to use their own blood or blood from a designated donor (like a family member) for transfusions, unless it's an emergency, there's insufficient time to arrange it, or the healthcare facility already has a process for patient-provided blood. It prohibits healthcare facilities from blocking this option and provides liability protection for providers if injuries occur from using such blood, unless the provider was grossly negligent. The bill directly affects patients needing transfusions and Utah healthcare facilities, taking effect in May 2026. It defines key terms and aligns with federal blood collection laws, with no funding impact.
HB 295, the "Overdose Amendments," updates Utah's criminal code to better address overdose situations. It expands the affirmative defense for reporting overdoses to include both the person experiencing the overdose and anyone who stays with them during the event. The bill also creates a new option for courts to dismiss first-time drug offenses if the individual commits to substance abuse treatment, and clarifies that reporting an overdose can be used as a sentencing mitigating factor for both parties involved. These changes aim to reduce criminal penalties for overdose-related incidents while encouraging treatment engagement.
HB 442 requires manufacturers of menstrual products sold in Utah to list specific chemicals (like lead, cadmium, arsenic, and PFAS) and intentionally added ingredients on product packaging. It directly affects manufacturers of tampons, sanitary napkins, menstrual cups, and similar products sold in the state. The Division of Consumer Protection will enforce these labeling rules and create related regulations. This bill increases transparency about ingredients in feminine hygiene products without changing product safety standards or requiring new funding.
HB 14 extends the expiration date for Utah's Behavior Analyst Licensing Act from July 1, 2026, to July 1, 2036. This change ensures the law governing behavior analyst licensure remains in effect for an additional decade, preventing its automatic repeal. The bill includes minor technical adjustments to the relevant code but does not alter licensing requirements for behavior analysts. This extension directly affects behavior analysts and the state's regulatory process for their professional licensing.
HB 28 extends the expiration dates for several health-related programs and committees under Utah's Department of Health and Human Services. It specifically delays the sunset (repeal) of programs like the Rare Disease Advisory Council Grant Program, Newborn Hearing Screening Committee, Mobile Crisis Outreach Team Grant Program, and Behavioral Health Receiving Center Grant Program, pushing their expiration dates from 2026 to 2036 or later. The bill amends Utah Code sections to adjust these repeal deadlines without creating new programs or appropriating funds. These changes directly affect the ongoing operation of these advisory bodies and grant initiatives, allowing them to continue functioning past their original expiration dates.
HB 70 requires Utah's Department of Health and Human Services to implement a new electronic health record system for inmate care by 2026, based on a working group's recommendations. It makes funds for unexpected high-cost correctional health care non-lapsing (meaning they won't expire if unused), and mandates a treatment plan for all inmates with substance use disorders, including medication-based treatment. The bill also sets accreditation standards for correctional health facilities and allows parole boards to consider health examiner reports when deciding parole conditions. These changes directly affect inmates in Utah's correctional facilities, the Department of Health and Human Services, and the Department of Corrections.
HB 356 clarifies Utah's rules for the federal 340B drug discount program, which provides discounted medications to eligible healthcare organizations. It defines key terms like "340B covered entity" (e.g., hospitals or clinics participating in the federal program) and prohibits drug manufacturers from restricting contracts between pharmacies and these entities or requiring excessive data sharing beyond federal requirements. The bill directly affects 340B-covered entities, pharmacies, and drug manufacturers by ensuring they cannot interfere with program participation or impose unnecessary conditions. It makes technical updates to Utah law without new funding, aligning state rules with federal program standards.